GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 39 filers reported holding GALMED PHARMACEUTICALS LTD in Q3 2018. The put-call ratio across all filers is 34.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $318,000 | -12.6% | 200,000 | 0.0% | 0.33% | -0.6% |
Q4 2021 | $364,000 | -34.8% | 200,000 | 0.0% | 0.33% | -32.7% |
Q3 2021 | $558,000 | -8.2% | 200,000 | 0.0% | 0.50% | -2.7% |
Q2 2021 | $608,000 | -11.4% | 200,000 | 0.0% | 0.51% | -15.6% |
Q1 2021 | $686,000 | +10.3% | 200,000 | 0.0% | 0.60% | +10.0% |
Q4 2020 | $622,000 | -11.9% | 200,000 | 0.0% | 0.55% | -28.5% |
Q3 2020 | $706,000 | +47.7% | 200,000 | +100.0% | 0.77% | +42.0% |
Q2 2020 | $478,000 | +38.2% | 100,000 | 0.0% | 0.54% | +16.1% |
Q1 2020 | $346,000 | -40.1% | 100,000 | 0.0% | 0.47% | -24.4% |
Q4 2019 | $578,000 | +72.5% | 100,000 | +42.9% | 0.62% | +47.4% |
Q3 2019 | $335,000 | -35.0% | 70,000 | 0.0% | 0.42% | -25.0% |
Q2 2019 | $515,000 | -29.9% | 70,000 | -22.2% | 0.56% | -23.4% |
Q1 2019 | $735,000 | +19.5% | 90,000 | 0.0% | 0.73% | -5.7% |
Q4 2018 | $615,000 | -49.7% | 90,000 | 0.0% | 0.77% | -40.6% |
Q3 2018 | $1,222,000 | +8.0% | 90,000 | -5.3% | 1.30% | +13.5% |
Q2 2018 | $1,131,000 | +103.1% | 95,000 | -5.0% | 1.14% | +70.9% |
Q1 2018 | $557,000 | -42.0% | 100,000 | -4.8% | 0.67% | -44.7% |
Q4 2017 | $961,000 | +0.1% | 105,000 | 0.0% | 1.21% | +20.1% |
Q3 2017 | $960,000 | +29.0% | 105,000 | -12.5% | 1.01% | +35.0% |
Q2 2017 | $744,000 | +26.7% | 120,000 | 0.0% | 0.75% | +25.8% |
Q1 2017 | $587,000 | +39.4% | 120,000 | 0.0% | 0.59% | +24.6% |
Q4 2016 | $421,000 | +58.3% | 120,000 | +100.0% | 0.48% | +66.4% |
Q3 2016 | $266,000 | – | 60,000 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|